Table 2. Morphologic and Metabolic Evaluation of Nodular Invasive Non-Mucinous ADCs According to Predominant Histologic Subtype.

Characteristics	Lepidic (n = 86)	Acinar (n = 172)	Papillary (n = 24)	Micropapillary (n = 4)	Solid (n = 43)
Morphologic evaluation
Size (mm)	18 ± 6	21 ± 6	22 ± 5	25 ± 4	21 ± 6
TDR	83.2 ± 24.8	43.1 ± 29.2	30.0 ± 15.4	26.4 ± 18.6	30.3 ± 22.9
Margin
Smooth	49 (57)	41 (24)	2 (8)	0 (0)	8 (19)
Lobulated or spiculated	37 (43)	131 (76)	22 (92)	4 (100)	35 (81)
Metabolic evaluation
SUVmax, mean ± SD	1.2 ± 1.5	5.1 ± 3.8	5.5 ± 3.3	6.3 ± 4.3	8.9 ± 4.7
Morphologic malignancy	11 (13)	92 (53)	18 (75)	3 (75)	28 (65)
Metabolic malignancy	10 (12)	105 (61)	15 (63)	3 (75)	37 (86)
M-M dissociation
Positive	6 (7)	21 (12)	4 (17)	1 (25)	2 (5)
Negative	80 (93)	151 (88)	20 (83)	3 (75)	41 (95)